Italy Medical Device Second Opinion Market

ID: MRFR/MED/45964-HCR
128 Pages
Rahul Gotadki
Last Updated: April 06, 2026
Italy Medical Device Second Opinion Market Research Report By Application Outlook (Cancer, Diabetes, Cardiac Disorders, Neurological Disorders, Respiratory Disorders, Ocular Disorders), By Source of Service Outlook (In-House, Outsourced), By Services Outlook (Medical Condition Management, Post-Acute Care Nursing, Medical Peer Review Services) and By Type Outlook (Hospitals Physicians/Specialties, Online Physicians Portal, Medical Second Opinion Companies, Health Insurance Companies) - Growth & Industry Forecast 2025 To 2035
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Italy Medical Device Second Opinion Market

Market Size

Forecast Period2025 - 2035
CAGR (2025 - 2035)12.92%
2024 Market Size$ 0.2 Billion
2025 Market Size$ 0.23 Billion
2035 Market Size$ 0.77 Billion

Key Players

MediGuide
Best Doctors
Second Opinion
Cigna Global Re
Teladoc Health
Mayo Clinic
Opportunities
  • Growing Awareness of Patient Rights
  • Rising Incidence of Chronic Diseases
  • Increasing Demand for Quality Healthcare
  1. 1 SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS
    1. 1.1 EXECUTIVE SUMMARY
      1. 1.1.1 Market Overview
      2. 1.1.2 Key Findings
      3. 1.1.3 Market Segmentation
      4. 1.1.4 Competitive Landscape
      5. 1.1.5 Challenges and Opportunities
      6. 1.1.6 Future Outlook
  2. 2 SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE
    1. 2.1 MARKET INTRODUCTION
      1. 2.1.1 Definition
      2. 2.1.2 Scope of the study
        1. 2.1.2.1 Research Objective
        2. 2.1.2.2 Assumption
        3. 2.1.2.3 Limitations
    2. 2.2 RESEARCH METHODOLOGY
      1. 2.2.1 Overview
      2. 2.2.2 Data Mining
      3. 2.2.3 Secondary Research
      4. 2.2.4 Primary Research
        1. 2.2.4.1 Primary Interviews and Information Gathering Process
        2. 2.2.4.2 Breakdown of Primary Respondents
      5. 2.2.5 Forecasting Model
      6. 2.2.6 Market Size Estimation
        1. 2.2.6.1 Bottom-Up Approach
        2. 2.2.6.2 Top-Down Approach
      7. 2.2.7 Data Triangulation
      8. 2.2.8 Validation
  3. 3 SECTION III: QUALITATIVE ANALYSIS
    1. 3.1 MARKET DYNAMICS
      1. 3.1.1 Overview
      2. 3.1.2 Drivers
      3. 3.1.3 Restraints
      4. 3.1.4 Opportunities
    2. 3.2 MARKET FACTOR ANALYSIS
      1. 3.2.1 Value chain Analysis
      2. 3.2.2 Porter's Five Forces Analysis
        1. 3.2.2.1 Bargaining Power of Suppliers
        2. 3.2.2.2 Bargaining Power of Buyers
        3. 3.2.2.3 Threat of New Entrants
        4. 3.2.2.4 Threat of Substitutes
        5. 3.2.2.5 Intensity of Rivalry
      3. 3.2.3 COVID-19 Impact Analysis
        1. 3.2.3.1 Market Impact Analysis
        2. 3.2.3.2 Regional Impact
        3. 3.2.3.3 Opportunity and Threat Analysis
  4. 4 SECTION IV: QUANTITATIVE ANALYSIS
    1. 4.1 Healthcare, BY Service Type (USD Billion)
      1. 4.1.1 Telemedicine
      2. 4.1.2 In-Person Consultation
      3. 4.1.3 Remote Review
      4. 4.1.4 Integrated Services
    2. 4.2 Healthcare, BY Medical Specialty (USD Billion)
      1. 4.2.1 Oncology
      2. 4.2.2 Cardiology
      3. 4.2.3 Neurology
      4. 4.2.4 Orthopedics
    3. 4.3 Healthcare, BY Patient Demographics (USD Billion)
      1. 4.3.1 Adults
      2. 4.3.2 Pediatrics
      3. 4.3.3 Geriatrics
      4. 4.3.4 Women
      5. 4.3.5 Men
    4. 4.4 Healthcare, BY Insurance Coverage (USD Billion)
      1. 4.4.1 Private Insurance
      2. 4.4.2 Public Insurance
      3. 4.4.3 Self-Pay
      4. 4.4.4 Employer-Sponsored
    5. 4.5 Healthcare, BY Technology Utilization (USD Billion)
      1. 4.5.1 Mobile Applications
      2. 4.5.2 Web Platforms
      3. 4.5.3 Artificial Intelligence
      4. 4.5.4 Data Analytics
  5. 5 SECTION V: COMPETITIVE ANALYSIS
    1. 5.1 Competitive Landscape
      1. 5.1.1 Overview
      2. 5.1.2 Competitive Analysis
      3. 5.1.3 Market share Analysis
      4. 5.1.4 Major Growth Strategy in the Healthcare
      5. 5.1.5 Competitive Benchmarking
      6. 5.1.6 Leading Players in Terms of Number of Developments in the Healthcare
      7. 5.1.7 Key developments and growth strategies
        1. 5.1.7.1 New Product Launch/Service Deployment
        2. 5.1.7.2 Merger & Acquisitions
        3. 5.1.7.3 Joint Ventures
      8. 5.1.8 Major Players Financial Matrix
        1. 5.1.8.1 Sales and Operating Income
        2. 5.1.8.2 Major Players R&D Expenditure. 2023
    2. 5.2 Company Profiles
      1. 5.2.1 MediGuide (IT)
        1. 5.2.1.1 Financial Overview
        2. 5.2.1.2 Products Offered
        3. 5.2.1.3 Key Developments
        4. 5.2.1.4 SWOT Analysis
        5. 5.2.1.5 Key Strategies
      2. 5.2.2 Best Doctors (IT)
        1. 5.2.2.1 Financial Overview
        2. 5.2.2.2 Products Offered
        3. 5.2.2.3 Key Developments
        4. 5.2.2.4 SWOT Analysis
        5. 5.2.2.5 Key Strategies
      3. 5.2.3 Second Opinion (IT)
        1. 5.2.3.1 Financial Overview
        2. 5.2.3.2 Products Offered
        3. 5.2.3.3 Key Developments
        4. 5.2.3.4 SWOT Analysis
        5. 5.2.3.5 Key Strategies
      4. 5.2.4 Cigna Global Re (IT)
        1. 5.2.4.1 Financial Overview
        2. 5.2.4.2 Products Offered
        3. 5.2.4.3 Key Developments
        4. 5.2.4.4 SWOT Analysis
        5. 5.2.4.5 Key Strategies
      5. 5.2.5 Teladoc Health (IT)
        1. 5.2.5.1 Financial Overview
        2. 5.2.5.2 Products Offered
        3. 5.2.5.3 Key Developments
        4. 5.2.5.4 SWOT Analysis
        5. 5.2.5.5 Key Strategies
      6. 5.2.6 Mayo Clinic (IT)
        1. 5.2.6.1 Financial Overview
        2. 5.2.6.2 Products Offered
        3. 5.2.6.3 Key Developments
        4. 5.2.6.4 SWOT Analysis
        5. 5.2.6.5 Key Strategies
      7. 5.2.7 Cleveland Clinic (IT)
        1. 5.2.7.1 Financial Overview
        2. 5.2.7.2 Products Offered
        3. 5.2.7.3 Key Developments
        4. 5.2.7.4 SWOT Analysis
        5. 5.2.7.5 Key Strategies
      8. 5.2.8 Bupa Global (IT)
        1. 5.2.8.1 Financial Overview
        2. 5.2.8.2 Products Offered
        3. 5.2.8.3 Key Developments
        4. 5.2.8.4 SWOT Analysis
        5. 5.2.8.5 Key Strategies
    3. 5.3 Appendix
      1. 5.3.1 References
      2. 5.3.2 Related Reports
  6. 6 LIST OF FIGURES
    1. 6.1 MARKET SYNOPSIS
    2. 6.2 ITALY MARKET ANALYSIS BY SERVICE TYPE
    3. 6.3 ITALY MARKET ANALYSIS BY MEDICAL SPECIALTY
    4. 6.4 ITALY MARKET ANALYSIS BY PATIENT DEMOGRAPHICS
    5. 6.5 ITALY MARKET ANALYSIS BY INSURANCE COVERAGE
    6. 6.6 ITALY MARKET ANALYSIS BY TECHNOLOGY UTILIZATION
    7. 6.7 KEY BUYING CRITERIA OF HEALTHCARE
    8. 6.8 RESEARCH PROCESS OF MRFR
    9. 6.9 DRO ANALYSIS OF HEALTHCARE
    10. 6.10 DRIVERS IMPACT ANALYSIS: HEALTHCARE
    11. 6.11 RESTRAINTS IMPACT ANALYSIS: HEALTHCARE
    12. 6.12 SUPPLY / VALUE CHAIN: HEALTHCARE
    13. 6.13 HEALTHCARE, BY SERVICE TYPE, 2024 (% SHARE)
    14. 6.14 HEALTHCARE, BY SERVICE TYPE, 2024 TO 2035 (USD Billion)
    15. 6.15 HEALTHCARE, BY MEDICAL SPECIALTY, 2024 (% SHARE)
    16. 6.16 HEALTHCARE, BY MEDICAL SPECIALTY, 2024 TO 2035 (USD Billion)
    17. 6.17 HEALTHCARE, BY PATIENT DEMOGRAPHICS, 2024 (% SHARE)
    18. 6.18 HEALTHCARE, BY PATIENT DEMOGRAPHICS, 2024 TO 2035 (USD Billion)
    19. 6.19 HEALTHCARE, BY INSURANCE COVERAGE, 2024 (% SHARE)
    20. 6.20 HEALTHCARE, BY INSURANCE COVERAGE, 2024 TO 2035 (USD Billion)
    21. 6.21 HEALTHCARE, BY TECHNOLOGY UTILIZATION, 2024 (% SHARE)
    22. 6.22 HEALTHCARE, BY TECHNOLOGY UTILIZATION, 2024 TO 2035 (USD Billion)
    23. 6.23 BENCHMARKING OF MAJOR COMPETITORS
  7. 7 LIST OF TABLES
    1. 7.1 LIST OF ASSUMPTIONS
  8. 7.1.1
    1. 7.2 Italy MARKET SIZE ESTIMATES; FORECAST
      1. 7.2.1 BY SERVICE TYPE, 2026-2035 (USD Billion)
      2. 7.2.2 BY MEDICAL SPECIALTY, 2026-2035 (USD Billion)
      3. 7.2.3 BY PATIENT DEMOGRAPHICS, 2026-2035 (USD Billion)
      4. 7.2.4 BY INSURANCE COVERAGE, 2026-2035 (USD Billion)
      5. 7.2.5 BY TECHNOLOGY UTILIZATION, 2026-2035 (USD Billion)
    2. 7.3 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
  9. 7.3.1
    1. 7.4 ACQUISITION/PARTNERSHIP
  10. 7.4.1

Italy Medical Device Second Opinion Market Segmentation

Italy Medical Device Second Opinion Market By Service Type (USD Billion, 2026-2035)

  • Telemedicine
  • In-Person Consultation
  • Remote Review
  • Integrated Services

Italy Medical Device Second Opinion Market By Medical Specialty (USD Billion, 2026-2035)

  • Oncology
  • Cardiology
  • Neurology
  • Orthopedics

Italy Medical Device Second Opinion Market By Patient Demographics (USD Billion, 2026-2035)

  • Adults
  • Pediatrics
  • Geriatrics
  • Women
  • Men

Italy Medical Device Second Opinion Market By Insurance Coverage (USD Billion, 2026-2035)

  • Private Insurance
  • Public Insurance
  • Self-Pay
  • Employer-Sponsored

Italy Medical Device Second Opinion Market By Technology Utilization (USD Billion, 2026-2035)

  • Mobile Applications
  • Web Platforms
  • Artificial Intelligence
  • Data Analytics